AI has the potential to change practice patterns, improve imaging, and inform treatment planning for patients with brain tumors.
Nicholas Blondin, MD
Advertisement
Articles by Nicholas Blondin, MD
Oncology clinicians can effectively collaborate with neuroradiologists using advanced techniques to improve brain tumor characterization.
Nicholas Blondin, MD, discusses the latest advancements in immunotherapy for brain cancer as well as emerging strategies, including CAR T-cell therapy.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Zenocutuzumab Earns FDA National Priority Voucher in Cholangiocarcinoma
2
124 Real-World Progression-Free Survival 2 and Tumor Response of CDK4/6is + Aromatase Inhibitor in Patients With HR+/HER2– Metastatic Breast Cancer
3
FDA Clears AI Stratification Tool in HR+/HER2– Invasive Breast Cancer
4
FDA Approves Zenocutuzumab in NRG1+ Cholangiocarcinoma Post Systemic Therapy
5